AHSCX: Alger Health Sciences C

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Fixed income news, reports, video and more.

Municipal bonds news, reports, video and more.

Practice management news, reports, video and more.

Portfolio management news, reports, video and more.

Retirement news, reports, video and more.

Learn from industry thought leaders and expert market participants.

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

AHSCX Alger Health Sciences C


Profile

AHSCX - Profile

Vitals

  • YTD Return 11.5%
  • 3 Yr Annualized Return 6.3%
  • 5 Yr Annualized Return 1.2%
  • Net Assets $278 M
  • Holdings in Top 10 34.8%

52 WEEK LOW AND HIGH

$23.02
$16.02
$23.02

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.89%

SALES FEES

  • Front Load N/A
  • Deferred Load 1.00%

BROKERAGE FEES

  • Turnover 148.78%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $1,000
  • IRA $500

Fund Classification


Distributions

  • YTD Total Return 11.5%
  • 3 Yr Annualized Total Return 6.3%
  • 5 Yr Annualized Total Return 1.2%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -1.12%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Alger Health Sciences Fund
  • Fund Family Name
    Alger
  • Inception Date
    May 01, 2002
  • Shares Outstanding
    N/A
  • Share Class
    C
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Daniel Chung

Fund Description

The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies of any market capitalization that are engaged in the health sciences sector. It can invest in foreign securities.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.


Categories

Performance

AHSCX - Performance

Return Ranking - Trailing

Period AHSCX Return Category Return Low Category Return High Rank in Category (%)
YTD 11.5% -9.0% 17.9% 17.69%
1 Yr 3.8% -12.1% 25.9% 88.98%
3 Yr 6.3%* -13.8% 23.1% 34.23%
5 Yr 1.2%* -11.4% 11.3% 26.92%
10 Yr 4.7%* -1.0% 18.5% 75.00%

* Annualized

Return Ranking - Calendar

Period AHSCX Return Category Return Low Category Return High Rank in Category (%)
2019 10.7% 5.7% 55.4% 94.87%
2018 -4.6% -25.3% 21.5% 31.53%
2017 31.1% -10.8% 43.9% 6.42%
2016 -4.1% -31.6% 6.9% 7.55%
2015 -16.6% -20.4% 13.8% 98.02%

Total Return Ranking - Trailing

Period AHSCX Return Category Return Low Category Return High Rank in Category (%)
YTD 11.5% -9.0% 17.9% 17.69%
1 Yr 3.8% -12.1% 25.9% 88.98%
3 Yr 6.3%* -13.8% 26.2% 45.95%
5 Yr 1.2%* -11.4% 15.2% 56.73%
10 Yr 4.7%* -1.0% 20.1% 88.10%

* Annualized

Total Return Ranking - Calendar

Period AHSCX Return Category Return Low Category Return High Rank in Category (%)
2019 10.7% 5.7% 55.4% 94.87%
2018 -4.6% -25.3% 22.2% 39.64%
2017 31.1% -10.8% 45.8% 9.17%
2016 -4.1% -26.4% 8.7% 9.43%
2015 -16.6% -16.6% 15.2% 100.00%

NAV & Total Return History


Holdings

AHSCX - Holdings

Concentration Analysis

AHSCX Category Low Category High AHSCX % Rank
Net Assets 278 M 2.3 M 48.4 B 70.15%
Number of Holdings 104 27 433 29.10%
Net Assets in Top 10 72 M 579 K 16.9 B 71.64%
Weighting of Top 10 34.75% 21.5% 76.0% 80.60%

Top 10 Holdings

  1. Vertex Pharmaceuticals Inc 4.94%
  2. UnitedHealth Group Inc 4.81%
  3. DexCom Inc 4.03%
  4. Eli Lilly and Co 3.62%
  5. Bristol-Myers Squibb Company 3.07%
  6. Gilead Sciences Inc 2.96%
  7. Tolero Cdr/Rec 2.93%
  8. AbbVie Inc 2.87%
  9. Sarepta Therapeutics Inc 2.79%
  10. Danaher Corp 2.74%

Asset Allocation

Weighting Return Low Return High AHSCX % Rank
Stocks
94.22% 65.31% 100.23% 73.13%
Other
2.93% -1.93% 9.19% 9.70%
Cash
2.51% -0.23% 34.69% 41.79%
Preferred Stocks
0.34% 0.00% 4.57% 6.72%
Convertible Bonds
0.00% 0.00% 0.00% 30.60%
Bonds
0.00% 0.00% 16.54% 37.31%

Stock Sector Breakdown

Weighting Return Low Return High AHSCX % Rank
Healthcare
97.15% 60.00% 100.00% 93.28%
Financial Services
2.00% 0.00% 2.00% 1.49%
Real Estate
0.85% 0.00% 5.63% 5.22%
Utilities
0.00% 0.00% 0.00% 30.60%
Technology
0.00% 0.00% 15.32% 39.55%
Industrials
0.00% 0.00% 3.92% 34.33%
Energy
0.00% 0.00% 0.33% 31.34%
Communication Services
0.00% 0.00% 5.13% 34.33%
Consumer Defense
0.00% 0.00% 36.48% 37.31%
Consumer Cyclical
0.00% 0.00% 0.96% 33.58%
Basic Materials
0.00% 0.00% 2.64% 43.28%

Stock Geographic Breakdown

Weighting Return Low Return High AHSCX % Rank
US
80.39% 52.09% 99.18% 43.28%
Non US
13.83% 0.00% 44.37% 62.69%

Expenses

AHSCX - Expenses

Operational Fees

AHSCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.89% 0.10% 25.14% 26.15%
Management Fee 0.55% 0.00% 1.30% 17.91%
12b-1 Fee 1.00% 0.00% 1.00% 78.08%
Administrative Fee 0.03% 0.03% 0.40% 4.76%

Sales Fees

AHSCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load 1.00% 1.00% 5.00% 40.91%

Trading Fees

AHSCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% 21.95%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

AHSCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 148.78% 0.70% 248.00% 93.85%

Distributions

AHSCX - Distributions

Dividend Yield Analysis

AHSCX Category Low Category High AHSCX % Rank
Dividend Yield 0.00% 0.00% 0.06% 32.09%

Dividend Distribution Analysis

AHSCX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Semi-Annually Annually

Net Income Ratio Analysis

AHSCX Category Low Category High AHSCX % Rank
Net Income Ratio -1.12% -2.53% 2.12% 90.77%

Capital Gain Distribution Analysis

AHSCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

AHSCX - Fund Manager Analysis

Managers

Daniel Chung


Start Date

Tenure

Tenure Rank

Oct 01, 2005

14.67

14.7%

Dan Chung, CFA is Chief Executive Officer, Chief Investment Officer and Portfolio Manager of several Alger strategies. Dan joined Alger in 1994 and has 25 years of investment experience. He was named Chief Investment Officer in September 2001, President in 2003, and CEO in 2006. Dan graduated from Stanford University with B.A. and B.S. degrees, with Distinction and Phi Beta Kappa, in 1984. He earned his J.D. magna cum laude from Harvard Law School in 1987, where he was an editor of the Harvard Law Review. After law school, he served as law clerk for the Honorable Justice Anthony M. Kennedy, United States Supreme Court. He joined Simpson Thacher & Bartlett LLP in New York City in 1989 and earned an L.L.M. from New York University. Dan is a CFA charterholder and a member of the CFA Institute. Throughout his tenure at Alger, Dan has made numerous TV appearances on Bloomberg, CNBC, and Fox Business. Dan has also been featured and quoted frequently in Barron’s, Citywire, Forbes, Investment News, Pensions & Investments, USA Today, and the Wall Street Journal.

Teresa McRoberts


Start Date

Tenure

Tenure Rank

Feb 12, 2015

5.3

5.3%

Teresa McRoberts is Senior Vice President, Senior Analyst, and Portfolio Manager. She first joined Alger in 1994. Before rejoining Alger in 2015, Teresa was the portfolio manager at Bienville Health Science Partners, a company she founded. Her previous experience includes health care portfolio manager roles at Galleon Group, Carlyle Blue Wave Partners, and Tribeca Global Management (Citigroup). Prior to that, she returned to Alger in 2001 as Senior Health Care Analyst and Portfolio Manager. Before returning to Alger, she was a portfolio manager and principal at Morgan Stanley. Her prior experience includes working as a health care analyst at Alger, and analyst and corporate finance roles at JP Morgan. Teresa earned her B.A. from Oberlin College and her M.B.A. from Columbia University.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.12 22.72 8.86 20.1